ABP-671 is a class 1 innovative chemotherapeutic drug for the treatment of gout and hyperuricemia, currently in Phase 2b/3 clinical trials for gout in China and overseas. The Product reduces renal ...
Gout is a type of arthritis characterized by severe pain, swelling, and stiffness in a joint, most often the big toe. It ...
A recent study presented by Orit Cohen Barak in the ACR Convergence 2024 showed that with the extra advantage of a ...
Atom Therapeutics partners with China Medical System to commercialize lingdolinurad for gout and hyperuricemia in China, Hong ...
Officials said Bhatia allegedly procured tablets of phenylbutazone, piroxicam and dexamethasone from several suppliers in ...
China Medical System (CHSYF) entered into an Exclusive Commercialization Agreement with Atom Therapeutics of class 1 innovative drug ABP-671 ...
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback